CD47 and cancer: In particular, the ability of the GPR84 agonist 6-OAU to promote phagocytosis of cancer cells induced by CD47 blockage and the specific expression of GPR84 in TAMs12 implied a potential role of GPR84 in cancer immune surveillance.